![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Vivistim Stroke Rehabilitation System
FDA Approves Vivistim Stroke Rehabilitation System
![Red_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Red_Approved_Stamp.gif?t=1578447203&width=430)
The FDA has approved Dallas, Tex.-based MicroTransponder’s Vivistim vagus nerve stimulation (VNS) system for rehabilitation of stroke patients.
The agency called the device "a first-of-its-kind, drug-free rehabilitation system” to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke.
The Vivistim system includes a pulse generator placed just under the skin in the patient’s chest, which generates a mild electrical pulse delivered to electrodes placed on the left side of the neck where the vagus nerve is located.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct